AKAP12

AKAP12 Full Name

A kinase (PRKA) anchor protein 12

AKAP12 Introduction

A Kinase Anchoring Protein 12 is a protein-coding gene that encodes a scaffolding protein involved in cellular signaling regulation. It is widely expressed across various tissues, with prominent presence in cells involved in growth, differentiation, and tissue repair. As a scaffolding molecule, it organizes and compartmentalizes signaling enzymes, ensuring precise and efficient signal transduction. Its ability to coordinate multiple signaling pathways is critical for maintaining cellular homeostasis and regulating various physiological processes.The protein encoded by the gene features conserved domains that facilitate binding to protein kinase A and other signaling molecules. It has structural motifs that support its role as a scaffolding protein, enabling it to form stable complexes with target enzymes and signaling partners. These structural traits are essential for its ability to anchor signaling molecules to specific subcellular locations, ensuring targeted and efficient signal transmission. The protein's structure also allows for post-translational modifications that modulate its binding affinity and regulatory activity.

Figure 1. Schematic structure of AKAP12.

Genetic Variants and Links to Human Disease
Common genetic variants in the AKAP12 gene have been associated with several human diseases in genome-wide association studies. Variants near AKAP12 have been associated with blood pressure regulation and hypertension, consistent with the role of AKAP12 in vascular endothelial function. Variants in AKAP12 have also been associated with risk of colorectal cancer and with survival in patients with breast cancer, though the effect sizes are modest. Rare loss-of-function mutations in AKAP12 have not been definitively linked to a Mendelian disorder, suggesting that complete AKAP12 deficiency may be tolerated in humans or may cause a subtle phenotype that has not been recognized. However, given the role of AKAP12 in neuronal development, it is possible that some cases of neurodevelopmental delay or intellectual disability are caused by AKAP12 mutations, and sequencing studies are ongoing. In addition to genetic variants, the expression of AKAP12 is regulated by environmental factors, including hypoxia, inflammation, and oxidative stress, which can reduce AKAP12 levels through transcriptional repression or protein degradation. This environmentally induced downregulation of AKAP12 may contribute to the pathogenesis of diseases such as atherosclerosis, where reduced AKAP12 in endothelial cells may promote inflammation and plaque formation.

Related Pathways and Applications
Beta-adrenergic receptor signaling and cyclic AMP compartmentation, cell migration and focal adhesion dynamics, angiogenesis and vascular endothelial growth factor signaling, synaptic plasticity and long-term potentiation, cancer metastasis and tumor suppression, and cytoskeletal organization and actin remodeling. Recombinant AKAP12 fragments containing the protein kinase A binding domain are used for in vitro RII overlay assays and pull-down experiments to study PKA anchoring. Anti-AKAP12 antibodies are employed in immunohistochemistry to assess AKAP12 expression in tumor tissues and blood vessels and in co-immunoprecipitation to identify novel binding partners. AKAP12-knockout mice and AKAP12-overexpressing cell lines are valuable models for studying the role of AKAP12 in cell migration, angiogenesis, and cancer metastasis. Promoter methylation analysis of the AKAP12 gene is being developed as a diagnostic or prognostic biomarker for colorectal cancer and other malignancies, and demethylating agents are being explored as a strategy to restore AKAP12 expression in cancer cells.

Alternate Names for AKAP12

AKAP12; A kinase (PRKA) anchor protein 12; SSeCKS; AKAP250; A-kinase anchor protein 12; AKAP 250; kinase scaffold protein gravin; A-kinase anchor protein, 250kDa; Src-Suppressed C Kinase Substrate; myasthenia gravis autoantigen gravin;